Eur Rev Med Pharmacol Sci 2020; 24 (8): 4062-4063
DOI: 10.26355/eurrev_202004_20977

Are probiotics effective adjuvant therapeutic choice in patients with COVID-19?

L. Di Renzo, G. Merra, E. Esposito, A. De Lorenzo

Section of Clinical Nutrition and Nutrigenomic, Department of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy. giuseppe.merra@uniroma2.it

Free PDF Download

To cite this article

L. Di Renzo, G. Merra, E. Esposito, A. De Lorenzo
Are probiotics effective adjuvant therapeutic choice in patients with COVID-19?

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 8
Pages: 4062-4063
DOI: 10.26355/eurrev_202004_20977

Keywords Related articles:

  1. Editorial – High dose intravenous immunoglobulins as a therapeutic option for COVID-19 patients
  2. Inositol hexaphosphate (InsP6) as an effective topical treatment for patients receiving adjuvant chemotherapy after breast surgery
  3. MSCs transplantation may be a potential therapeutic strategy for COVID-19 treatment
  4. Procalcitonin is useful in driving the choice of early antibiotic treatment in patients with bloodstream infections
  5. SARS-CoV-2 causing pneumonia-associated respiratory disorder (COVID-19): diagnostic and proposed therapeutic options